Rating Change
Lake Street analysts initiated coverage on The Oncology Institute, Inc. (NASDAQ:TOI) with a Buy rating on July 06, 2026.
Rating Change Lake Street analysts initiated coverage on The Oncology Institute, Inc. (NASDAQ:TOI) with a Buy rating on July 06, 2026. Market Context The Oncology Institute, Inc.

Lake Street analysts initiated coverage on The Oncology Institute, Inc. (NASDAQ:TOI) with a Buy rating on July 06, 2026.
The Oncology Institute, Inc. operates in the Healthcare sector. The stock currently trades at $5.44 with a market capitalization of $370.4M.
Analyst coverage from Lake Street provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for The Oncology Institute, Inc..
Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.
Among the 10 most recent ratings: 10 Buy, 0 Hold, 0 Sell.
| Date | Firm | Rating | Price Target |
|---|---|---|---|
| Jul 06, 2026 | Lake Street | Buy | N/A |
| Jun 17, 2026 | Needham | Buy | N/A |
| Jun 08, 2026 | BTIG | Buy | N/A |
| Mar 13, 2026 | B. Riley Securities | Buy | N/A |
| Mar 13, 2026 | Needham | Buy | N/A |
Related Tools: Analyst Ratings Dashboard | View TOI Stock Page
A Buy rating from Lake Street reflects the analyst's outlook on The Oncology Institute, Inc. (NASDAQ:TOI). Analyst ratings are one factor investors consider alongside earnings, valuation, and sector trends.
Browse recent upgrades and downgrades on our Analyst Ratings Dashboard or the TOI forecast page.
Current market data
NASDAQ · TOI
$5.13
Down: -$1.26 · -19.72%
Live quote updated
Keep reading